EFI Lake Geneva Ventures
VC Fund
Geneva, Switzerland
EFI Lake Geneva Ventures is a seed and early-stage investment strategy.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries EFI Lake Geneva Ventures invests in
Stages EFI Lake Geneva Ventures invests in
Countries EFI Lake Geneva Ventures invests in
Round sizes
Round size
- Seed
- $2.5M–$3.8M
- Series B
- $5.1M–$16M
Investment Focus
Industry
- Health Care 5 (71%)
- Life Science 3 (43%)
- Biotechnology 2 (29%)
- Medical Device 2 (29%)
- Medical 1 (14%)
Stage
- Seed 3 (43%)
- Series B 2 (29%)
- Pre-Seed 1 (14%)
- Series A 1 (14%)
Country
- Switzerland 6 (86%)
- Germany 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies. | Seed / Apr 29, 2025 | |
|
|
Hemotune is a medical device company that develops a therapeutic blood purification platform for treatment of health ailments. | $15.6M / Series B / Mar 25, 2024 | |
|
|
Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland. | $5.1M / Series B / Sep 05, 2023 | |
|
|
EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients. | $15.7M / Series A / Jun 27, 2023 | |
|
|
Impossible Materials envisions future customers consuming more sustainable products produced in a circular economy. They contribute to this future by selling cellulose-based products to businesses. Plant-based cellulose white pigment and opacifier solutions have been developed for a variety of industries. | $3.8M / Seed / Apr 05, 2023 | |
|
|
FluoSphera is a discovery of efficient drugs with fewer adverse side effects and the reduction of animal experimentation, allowing companies to address the complexity of human physiological responses and protect populations from hazardous chemicals more effectively. | $1M / Pre-Seed / Mar 01, 2023 | |
|
|
Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch. | $2.5M / Seed / Feb 17, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does EFI Lake Geneva Ventures invest in?
EFI Lake Geneva Ventures invests primarily in Health Care, Life Science and Biotechnology startups, most often at Seed and Series B stage. Most of the 7 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is EFI Lake Geneva Ventures's check size?
EFI Lake Geneva Ventures typically joins rounds of $2.5M–$3.8M at Seed and $5.1M–$16M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds EFI Lake Geneva Ventures participates in.
When did EFI Lake Geneva Ventures last invest?
The most recent investment recorded for EFI Lake Geneva Ventures closed in Apr 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!